Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;71(6):353-69.
doi: 10.1111/nure.12024. Epub 2013 Apr 1.

Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders

Philip B Busbee  1 , Michael Rouse, Mitzi Nagarkatti, Prakash S Nagarkatti
Affiliations
Review

Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders

Philip B Busbee et al. Nutr Rev. 2013 Jun.

Abstract

The aim of this review is to discuss research involving ligands for the aryl hydrocarbon receptor (AhR) and their role in immunomodulation. While activation of the AhR is well known for its ability to regulate the biochemical and toxic effects of environmental chemicals, more recently an exciting discovery has been made indicating that AhR ligation can also regulate T-cell differentiation, specifically through activation of Foxp3(+) regulatory T cells (Tregs) and downregulation of the proinflammatory Th17 cells. Such findings have opened new avenues of research on the possibility of targeting the AhR to treat inflammatory and autoimmune diseases. Specifically, this review will discuss the current research involving natural and dietary AhR ligands. In addition, evidence indicating the potential use of these ligands in regulating inflammation in various diseases will be highlighted. The importance of the AhR in immunological processes can be illustrated by expression of this receptor on a majority of immune cell types. In addition, AhR signaling pathways have been reported to influence a number of genes responsible for mediating inflammation and other immune responses. As interest in the AhR and its ligands increases, it seems prudent to consolidate current research on the contributions of these ligands to immune regulation during the course of inflammatory diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. AhR domain structure
Domains: bHLH, basic helix-loop-helix; PAS, Per/Ahr-ARNT/Sim; glutamine-rich region.
Figure 2
Figure 2. AhR signaling pathway
(a) Ligand passes through plasma membrane into the cellular cytoplasm. (b) Ligand binds the cytosolic AhR complex. (c) The ligand-bound AhR complex is translocated into the nucleus. (d) The ligand-bound AhR complex dissociates from chaperone proteins after dimerization with ARNT. (e) Ligand-bound AhR/ARNT complex binds to DREs/XREs, (f) which leads to transcriptional activation of target genes.
Figure 3
Figure 3. AhR ligand structure and binding affinities
Binding affinities are based on half-maximal effective concentration (EC50) values as determined by induction or inhibition of CYP1A1 expression.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sun YV, Boverhof DR, Burgoon LD, et al. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. 2004;32:4512–4523. - PMC - PubMed
    1. Esser C. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochem Pharmacol. 2009;77:597–607. - PubMed
    1. Camacho IA, Nagarkatti M, Nagarkatti PS. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Toxicol Sci. 2004;78:96–106. - PubMed
    1. Esser C, Rannug A, Stockringer B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009;30:447–454. - PubMed
    1. Hahn ME, Karchner SI, Shapiro MA, et al. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AhR1 and AhR2) and the PAS family. Proc Natl Acad Sci U S A. 1997;95:13743–13748. - PMC - PubMed

Publication types

MeSH terms

Substances